Girl, 5, Ends 6 Months of Isolation Post-Transplant

A five-year-old girl named Freya Dixon has finally ended six months of rigorous isolation after undergoing a life-saving bone marrow transplant. Freya was diagnosed as an infant with Diamond-Blackfan anaemia, a condition characterized by insufficient red blood cell production. Her transplant, performed in September, was successful, but she subsequently developed a serious complication known as transplant-associated thrombotic microangiopathy (TMA).

Her mother described the past six months as incredibly challenging. Prior to the transplant, Freya endured over 70 blood transfusions and missed her first year of school. The bone marrow donation came from a 20-year-old man in Germany, offering hope that Freya might never need another transfusion. For the first time, her body is producing its own red blood cells.

Despite the transplant's success, Freya contracted a virus during her isolation, leading to TMA. A drug called Eculizumab may help stabilize this condition, though it is not routinely available on the NHS. Leeds Teaching Hospitals NHS Trust has approved the medication for three weeks, with further approval pending Freya's response. The family is balancing this new treatment with their joy at Freya's return to a more normal life, including starting school part-time.